| Wang, Jun |
NCT04728516: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients |
|
|
| Not yet recruiting | 4 | 2600 | RoW | Vonoprazan-based dual eradication therapy for two weeks, amoxicillin, Pantoprazole | Qilu Hospital of Shandong University | Acute Coronary Syndrome, Helicobacter Pylori Infection | 01/23 | 06/23 | | |
| Recruiting | 4 | 40 | RoW | Thymosin Alpha1, thymalfasin, Immunosuppressant, Prednisone, Cortisone, Mycophenolate Mofetil, Tacrolimus | Jun Wang | IrAE | 11/24 | 04/25 | | |
NCT05604859: Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS) |
|
|
| Recruiting | 4 | 350 | RoW | Methylprednisolone, intravenous immunoglobulin, Tocilizumab, Low molecular weight heparin, conventional treatment | Qin Ning | Severe Fever With Thrombocytopenia Syndrome | 12/23 | 06/24 | | |
NCT06009042: Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study |
|
|
| Recruiting | 4 | 100 | RoW | IVIG 20g/d, IVIG 10g/d | Tongji Hospital | HFRS (Hemorrhagic Fever With Renal Syndrome) | 06/24 | 06/24 | | |
NCT04726501: CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma |
|
|
| Recruiting | 4 | 200 | RoW | Combined chemotherapy with or without involved-field radiotherapy | Children's Cancer Group, China, Shanghai Children's Medical Center | Hodgkin Lymphoma | 12/25 | 12/27 | | |
NCT05830500: Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma |
|
|
| Recruiting | 4 | 360 | RoW | Anlotinib Hydrochloride Capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Medullary Thyroid Cancer | 06/27 | 12/28 | | |
| Recruiting | 3 | 315 | RoW | TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Stage III Non-small-cell Lung Cancer | 12/22 | 03/25 | | |
| Active, not recruiting | 3 | 291 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib | Loxo Oncology, Inc., Eli Lilly and Company | Medullary Thyroid Cancer | 05/23 | 02/26 | | |
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 450 | RoW | camrelizumab + famitinib, pembrolizumab, camrelizumab | Jiangsu HengRui Medicine Co., Ltd. | Non-small Cell Lung Cancer | 12/23 | 12/25 | | |
JADE, NCT06256588: A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 3 | 864 | Europe, Canada, Japan, US, RoW | Dostarlimab, Placebo | GlaxoSmithKline | Neoplasms, Head and Neck | 05/28 | 07/29 | | |
NCT06333821: A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma |
|
|
| Not yet recruiting | 3 | 460 | NA | Nimotuzumab, Cisplatin, External Beam Radiotherapy (EBRT), Brachytherapy, placebo for Nimotuzumab, placebo | Biotech Pharmaceutical Co., Ltd. | Cervical Cancer | 04/30 | 04/30 | | |
NCT06616532: PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 404 | RoW | PM8002, Paclitaxel, Topotecan | Biotheus Inc. | SCLC | 01/27 | 12/28 | | |
NCT04102982: Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer |
|
|
| Recruiting | 2 | 200 | RoW | Camrelizumab, Camrelizumab plus microwave ablation, Camrelizumab plus MWA | Shandong Provincial Hospital | NSCLC Stage IV | 10/21 | 02/22 | | |
NCT03977480: Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis |
|
|
| Terminated | 2 | 70 | RoW | Hemay007, Placebo | Tianjin Hemay Pharmaceutical Co., Ltd | Ulcerative Colitis | 08/22 | 08/22 | | |
NCT05254665: A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors |
|
|
| Not yet recruiting | 2 | 110 | RoW | Docetaxel Polymeric Micelles for Injection | Jiangsu Simcere Pharmaceutical Co., Ltd. | Advanced Solid Tumors | 12/22 | 03/24 | | |
NCT04286958: A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC |
|
|
| Recruiting | 2 | 40 | RoW | Camrelizumab | Hebei Medical University Fourth Hospital | Esophageal Cancer | 12/22 | 03/23 | | |
| Recruiting | 1/2 | 280 | RoW | SAF-189s, foritinib succinate | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Advanced Cancer, Advanced Solid Tumor, Lung Cancer, Nonsmall Cell | 12/22 | 03/26 | | |
TQB2618-AK105-Ib-02, NCT05783921: A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 1/2 | 60 | RoW | TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma | 08/24 | 01/25 | | |
| Recruiting | N/A | 120 | RoW | Acupuncture, Rehabilitation, Rehabilitation treatment | Shanghai University of Traditional Chinese Medicine, Fudan University | Ischemic Stroke, Paralysis | 12/21 | 12/21 | | |
| Recruiting | N/A | 630 | Europe, US, RoW | ROX index algorithm | Hospital Universitari Vall d'Hebron Research Institute | Acute Hypoxemic Respiratory Failure | 12/24 | 06/25 | | |
NCT03921281: Evaluating the Therapeutic Effect of Scalp Acupuncture Treatment for Motor Dysfunction in Children With Cerebral Palsy |
|
|
| Completed | N/A | 100 | RoW | scalp acupuncture treatment, Rehabilitation Treatment | Children's Hospital of Fudan University | Cerebral Palsy, Motor Dysfunction, Acupuncture | 12/22 | 12/22 | | |
NCT04853238: Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China |
|
|
| Completed | N/A | 1507 | RoW | Prospective observational cohort study | GlaxoSmithKline | Pulmonary Disease, Chronic Obstructive | 11/22 | 02/23 | | |
NCT05379491: Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation |
|
|
| Completed | N/A | 720 | RoW | 3 L PEG + linaclotide, 3 L PEG + placebo | Zhiguo Liu | Colonoscopy | 06/23 | 07/23 | | |
NCT05654857: The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu |
|
|
| Recruiting | N/A | 4000 | RoW | PCR test in the stool | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 08/23 | 08/23 | | |
PROFOUND, NCT06217900: a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（） |
|
|
| Recruiting | N/A | 16666 | RoW | | Shanghai Weihe Medical Laboratory Co., Ltd., Peking University People's Hospital | Cancer | 10/26 | 03/27 | | |
| Recruiting | N/A | 500 | RoW | | Tongji Hospital | HFRS | 12/23 | 12/23 | | |
NCT05513040: Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment |
|
|
| Recruiting | N/A | 300 | RoW | | Air Force Military Medical University, China | Functional Dyspepsia | 03/25 | 06/25 | | |
NCT05503940: Association of Multiple Medications With the Severity of Dyspepsia |
|
|
| Recruiting | N/A | 600 | RoW | | Air Force Military Medical University, China | Dyspepsia | 12/23 | 06/24 | | |
NCT05723731: Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Chronic Constipation |
|
|
| Terminated | N/A | 106 | RoW | taVNS, Laxative Agent | Air Force Military Medical University, China | Chronic Constipation | 07/23 | 09/23 | | |
NCT06330727: Effects of Coffee Consumption on Metabolic Markers in Adults With Prediabetes and Obesity |
|
|
| Recruiting | N/A | 100 | RoW | Coffee capsule, 0 sugar 0 fat black coffee, instant black coffee. Product standard code: Q/QC 0001S. Food production license number: SC10644190004159., Corn starch capsule, Edible corn starch. Product standard code: GB 31637. Food production license number: SC10313102300041. | Nanjing First Hospital, Nanjing Medical University | Prediabetes | 10/24 | 10/24 | | |
NCT05947461: Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac |
|
|
| Terminated | N/A | 1204 | RoW | 100mg diclofenac, 100mg indomethacin | Air Force Military Medical University, China | Post-ERCP Acute Pancreatitis, NSAIDs, Indomethacin, Diclofenac, Endoscopic Retrograde Cholangiopancreatography | 06/24 | 06/24 | | |
TACS, NCT06375408: Transcranial Alternating Current Stimulation Prevents Delirium in Patients With Subarachnoid Hemorrhage |
|
|
| Recruiting | N/A | 74 | RoW | Real transcranial alternating electrical stimulation, Sham transcranial alternating electrical stimulation | Xuanwu Hospital, Beijing | Subarachnoid Hemorrhage | 02/26 | 03/26 | | |
NCT06323265: A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer |
|
|
| Recruiting | N/A | 50 | RoW | Adebrelimab + chemotherapy, ±chest radiotherapy | Hebei Medical University Fourth Hospital | Extensive Stage Small Cell Lung Cancer | 04/25 | 04/26 | | |
NCT06063941: High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy |
|
|
| Completed | N/A | 450 | RoW | 1% Lugol's iodine solution, 5% Lugol's iodine solution | Xijing Hospital of Digestive Diseases, Ankang Central Hospital, The First Affiliated Hospital of ShiheziI University, Xi'an International Medical Center Hospital, Air Force 986 Hospital | Esophageal Squamous Cell Carcinoma | 04/24 | 04/24 | | |
| Not yet recruiting | N/A | 100 | NA | Magnetic resonance imaging scanning, FMT Protocol | LanZhou University | Inflammatory Bowel Diseases | 07/24 | 12/27 | | |
NCT06756139: Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia |
|
|
| Recruiting | N/A | 88 | RoW | cognitive behavioural therapy mobile application, Flupentixol and Melitracen Tablets | Air Force Military Medical University, China, Xi'an 986 Hospital, Shaanxi Second People's Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Tang-Du Hospital, Hainan People's Hospital | Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug | 11/25 | 11/25 | | |
NCT05717790: Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma |
|
|
| Recruiting | N/A | 288 | RoW | Nimotuzumab, h-R3, BIOMAb EGFR, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT | Fourth Affiliated Hospital of Guangxi Medical University, People's Hospital of Baise, Second Affiliated Hospital of Guangzhou Medical University, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin Medical University, China, LiuZhou People's Hospital, The First People's Hospital of Qinzhou, Wuzhou Red Cross Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities | Nasopharyngeal Carcinoma by AJCC V8 Stage | 11/24 | 11/27 | | |
NCT06777485: China Liver Cancer Clinical Registry Cohort Database |
|
|
| Recruiting | N/A | 10000 | RoW | Procedure/Surgery treatment, Anti-Tumor Drugs | Anhui Provincial Hospital | Liver Cancer | 01/35 | 01/35 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
NCT04558255: A Preliminary Study on the Detection of Plasma Markers in Early Diagnosis for Lung Cancer |
|
|
| Recruiting | N/A | 1000 | RoW | A machine-learning method which can robustly discriminate early-stage lung cancer patients from controls | Peking University People's Hospital | Lung Cancer | 12/20 | 12/21 | | |
NCT04326751: Evolution of Multiple Primary Lung Cancer (Evolution) |
|
|
| Not yet recruiting | N/A | 20 | NA | | Peking University People's Hospital, Guangzhou Burning Rock Medical Examination Institute Co., Ltd. | Multiple Primary Lung Cancers, Lung Cancer, Non Small Cell Lung Cancer | 12/23 | 12/23 | | |
NCT05524675: The Effect of Multiple Medications on the Incidence of Organic Dyspepsia |
|
|
| Recruiting | N/A | 500 | RoW | | Air Force Military Medical University, China | Dyspepsia | 12/23 | 06/24 | | |
| Not yet recruiting | N/A | 300 | RoW | | Peking University People's Hospital, Research Unit of Intelligence Diagnosis and treatment of early-stage non-small cell lung cancer, Chinese Academy of Medical Sciences | Non-small Cell Lung Cancer | 09/24 | 09/26 | | |
| Gao, Yuhuan |
NCT03934567: A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma |
|
|
| Recruiting | 2 | 96 | RoW | Abexinostat | Xynomic Pharmaceuticals, Inc. | Lymphoma, Follicular | 02/24 | 09/24 | | |
NCT03936153: Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) |
|
|
| Recruiting | 2 | 170 | RoW | abexinostat | Xynomic Pharmaceuticals, Inc. | Diffuse Large B-cell Lymphoma (DLBCL) | 12/24 | 05/25 | | |
| Wang, Wenqing |
NCT05970432: A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 2 | 160 | RoW | TQH2722 injection 300mg-150mg, TQH2722 injection 600mg-300mg, TQH2722 injection 900mg-450mg, TQH2722 injection matching Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Atopic Dermatitis | 03/24 | 03/24 | | |
